Cytokinetics | CYTK - Operating Expenses


Cytokinetics reported $200.58M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Acadia Pharmaceuticals USD 270.12M 2.55M Jun/2026
Amgen USD 11.69B 6.9B Jun/2026
Arca Biopharma USD 36.43M 2M Mar/2026
Bayer EUR 9.88B 452M Mar/2026
Biogen USD 2.98B 1.02B Jun/2026
Brainstorm Cell Therapeutics USD 2.05M 198K Mar/2026
Bristol-Myers Squibb USD 22.32B 2.25B Jun/2026
Capricor Therapeutics USD 29.16M 2.87M Dec/2025
Cytokinetics USD 200.58M 4.46M Mar/2026
Eisai JPY 209.6B 6.14B Jun/2026
Eli Lilly USD 10.52B 496M Jun/2026
Exelixis USD 359.47M 3.28M Mar/2026
Geron USD 52.07M 6.73M Mar/2026
Halozyme Therapeutics USD 192.19M 18.88M Mar/2026
Ionis Pharmaceuticals USD 370.24M 6.24M Jun/2026
Ligand Pharmaceuticals USD 34.35M 5.27M Mar/2026
Merck USD 15.77B 2.4B Jun/2026
Novartis USD 10.2B 912M Jun/2026
Pfizer USD 85.19B 4.91B Jun/2026
Regeneron Pharmaceuticals USD 31.71B 287.8M Jun/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
Sanofi EUR 9.92B 607M Jun/2026